Seaport Therapeutics Appoints Antony Loebel, M.D. as Chief Medical Officer and President of Clinical Development, and Lana Gladstein, J.D. as General Counsel
Position
General Counsel
Company
Seaport Therapeutics
BostonBiotechnologyTherapeuticsPharmaceuticalBiopharmaDescription
Seaport Therapeutics has expanded its executive team with the appointment of Antony Loebel, M.D., as Chief Medical Officer and President of Clinical Development, and Lana Gladstein, J.D., as General Counsel.
Quick answer
Seaport Therapeutics Appoints Antony Loebel, M.D. as Chief Medical Officer and President of Clinical Development, and Lana Gladstein, J.D. as General Counsel (June 18, 2024). Seaport Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new General Counsel at Seaport Therapeutics?
- Seaport Therapeutics named Lana Gladstein General Counsel, announced June 18, 2024.
- What did Seaport Therapeutics announce on June 18, 2024?
- Seaport Therapeutics has expanded its executive team with the appointment of Antony Loebel, M.D., as Chief Medical Officer and President of Clinical Development, and Lana Gladstein, J.D., as General Counsel.
- What does Seaport Therapeutics do?
- Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs.
- Where is Seaport Therapeutics based?
- Seaport Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- OnKure Therapeutics (June 19, 2024), AbbVie Inc. (June 20, 2024), Novita Pharmaceuticals (June 11, 2024) and MBX Biosciences, Inc. (June 25, 2024) also announced leadership changes within 45 days of Seaport Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- OnKure, Inc. Appoints Rogan Nunn as General Counsel and Secretary (June 19, 2024)
- AbbVie Appoints Roxanne S. Austin as Lead Independent Director (June 20, 2024)
- Novita Pharmaceuticals Appoints Dr. Jose Jimeno as Chief Medical Officer (June 11, 2024)
- MBX Biosciences Appoints Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (June 25, 2024)
- Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer (July 2, 2024)
- Contineum Therapeutics Appoints John Healy as General Counsel & Corporate Secretary (June 3, 2024)
Who to call at Seaport Therapeutics, and when
A new leader at Seaport Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Seaport Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Seaport Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Seaport Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Seaport Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Seaport Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.